Impact of Outpatient Administration of Cytarabine Consolidation Chemotherapy on Hospital Length of Stay in Adults with Acute Myeloid Leukemia
- Resource Type
- Article
- Authors
- Viiala, Nicholas; Pitiyarachchi, Omali; Range, Heather; Descallar, Joseph; Nguyen, Rebecca Han; Nguyen, John Dang Trinh; McEwan, Ashley Kate; Getta, Bartlomiej; Dunlop, Lindsay Cameron
- Source
- Blood; November 2023, Vol. 142 Issue: 1, Number 1 Supplement 1 p3723-3723, 1p
- Subject
- Language
- ISSN
- 00064971; 15280020
Background: Administration of 3-4 cycles of high/intermediate dose cytarabine (H/IDAC) reduces relapse of acute myeloid leukemia (AML) and bridges patients (pts) to allograft. There is no accepted standard model of safely delivering H/IDAC in these pts. To reduce reliance on inpatient (inpt) chemotherapy administration and safely avoid or forestall hospitalization during cycles, we developed an outpatient (outpt) protocol to deliver H/IDAC. Pts were assigned outpt or inpt treatment at their hematologist's discretion. We aimed to evaluate the benefits and safety of our model in this retrospective observational study.